Article
Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer.
The American journal of pathology - 1 Apr 1994
Ruizeveld de Winter J A, Janssen P J, Sleddens H M, Verleun-Mooijman M C, Trapman J, Brinkmann A O, Santerse A B, Schröder F H, van der Kwast T H
Abstract excerpt
Heterogeneity in human androgen receptor (hAR) expression in prostate cancer is considered to be implicated in tumor progression. hAR expression was therefore studied immunohistochemically in localized and locally progressive, hormone refractory (HR) prostate cancer. Because altered functional ac...
Topics
- Antibodies, Monoclonal
- Base Sequence
- Carcinoma
- DNA Primers
- Exons
- Gene Expression
- Hormones
- Humans
- Hyperplasia
- Immunoenzyme Techniques
- Male
- Metribolone
- Molecular Sequence Data
- Mutation
- Prostate